Guidelines for radio-iodine (131I) therapy in Graves' disease and thyroid cancer

Mori Y; Kusakabe K; Ikekubo K; Ishikawa N; Nakada K; Kanaya S; Misaki T; Yokoyama K; Kubo A; Higashi T; Itou K; Noguchi Y; Tsuchimochi S; Togawa T

首页> 外文期刊>核医学 >Guidelines for radio-iodine (131I) therapy in Graves' disease and thyroid cancer

【24h】

Guidelines for radio-iodine (131I) therapy in Graves' disease and thyroid cancer

机译：坟墓疾病和甲状腺癌中的无线电碘（131I）治疗指南

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Radio-iodine (131I) therapy has been using in Graves' disease and well differentiated thyroid cancer. The rules of control in the discharge from radio-isotope hospital were notified in 1999 in Japan. Guideline of the 131I therapy in Graves' disease and thyroid cancer were prepared by sub-group of Japanese Society of Nuclear Medicine.

机译：无线电 - 碘（131 I ）治疗已使用格雷夫斯病和良好分化型甲状腺癌。控制在从放射性同位素医院排放的规则在 1999年在日本进行了通报。在 131I治疗 Graves病和甲状腺癌的方针是由亚组核医学的日本社会的准备。

著录项

来源
《核医学》 |2005年第1期|共16页
作者
Mori Y; Kusakabe K; Ikekubo K; Ishikawa N; Nakada K; Kanaya S; Misaki T; Yokoyama K; Kubo A; Higashi T; Itou K; Noguchi Y; Tsuchimochi S; Togawa T;
展开▼
作者单位

Department of Radiology The Jikei University School of Medicine.;

展开▼
收录信息
原文格式 PDF
正文语种 jpn
中图分类特种医学;
关键词
Graves' Disease; Iodine Radioisotopes; Radiopharmaceuticals; Thyroid Neoplasms; 格雷夫斯病; 碘放射性同位素; 放射性药物; 甲状腺肿瘤;

机译：Graves' Disease;Iodine Radioisotopes;Radiopharmaceuticals;Thyroid Neoplasms;格雷夫斯病;碘放射性同位素;放射性药物;甲状腺肿瘤;

相似文献

外文文献
中文文献
专利

1. Guidelines for radio-iodine (131I) therapy in Graves' disease and thyroid cancer [J] . Mori Y, Kusakabe K, Ikekubo K, 核医学 . 2005,第1期

机译：格雷夫斯病和甲状腺癌的放射性碘（131I）治疗指南
2. High pre-therapy (99mTc)pertechnetate thyroid uptake, thyroid size and thyrostatic drugs: predictive factors of failure in (131I)iodide therapy in Graves' disease. [J] . Zantut Wittmann DE, Ramos CD, Santos AO, Nuclear Medicine Communications . 2005,第11期

机译：较高的治疗前（99mTc）高甲状腺摄取，甲状腺大小和甲状腺抑制药物：Graves病碘化（131I）治疗失败的预测因素。
3. Effect of lithium carbonate combined with 131I therapy on thyroid function as well as the Fas/FasL expression in peripheral blood of patients with Graves disease and leukopenia [J] . Ji Ma, Ji Zhang, Juan Xiao Journal of Hainan Medical University . 2017,第1期

机译：碳酸锂联合131I治疗对Graves病和白细胞减少症患者甲状腺功能以及外周血Fas / FasL表达的影响
4. Statistical approach for analysis of the credibility of high thyroid dose estimates based on in-vivo measurements of 131I thyroidal content for Belarusian population following the Chernobyl accident [C] . Sergey Shinkarev, Paul Voillequé, Yury Gavrilin, Congress of the International Radiation Protection Association;IRPA 12 . 2010

机译：基于切尔诺贝利事故后白俄罗斯人群体内131I甲状腺含量的体内测量，用于分析高甲状腺剂量估计值可信度的统计方法
5. Analyzing the role of thyroidal CD40 expression in the pathogenesis of Graves' disease. [D] . Huber, Amanda Katherine. 2011

机译：分析甲状腺CD40表达在Graves病发病机理中的作用。
6. Prediction of thyroidal 131I effective half-life in patients with Graves disease [O] . Ruiguo Zhang, Guizhi Zhang, Renfei Wang, 2017

机译：Graves病患者甲状腺131I有效半衰期的预测
7. Tratamento clínico com drogas antitireoidianas ou dose terapêutica de iodo-131 no controle do hipertireoidismo na doença de graves: avaliação dos custos e benefícios Anti-thyroid drugs or 131I therapy to control the hyperthyroidism of graves disease: a cost-effectiveness analysis [O] . Antônio Fiel Cruz Júnior, Míriam Hideco Takahashi, Cláudio Cordeiro Albino 2006

机译：用抗甲状腺药物或碘131治疗剂量控制严重疾病中甲亢的临床治疗：成本和收益的评估抗甲状腺药物或131I治疗控制严重甲状腺功能亢进症的成本-效益分析

Guidelines for radio-iodine (131I) therapy in Graves' disease and thyroid cancer

摘要

著录项

相似文献

相关主题

期刊订阅